JR

Janardhana Reddy Ambati

Active Director Director DIN 10285940
DIN 10285940 First appointment Aug 2023 Primary industry Professional Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Janardhana Reddy Ambati

Data last updated:

Janardhana Reddy Ambati is a Director at Novarica Meditech Private Limited (since 2023). The company operates in Professional Services.

DIN 10285940
Primary Designation Director
Industry Professional Services
First Appointment 21 Aug 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Novarica Meditech Private Limited U72100TS2023PTC176242
Director21 Aug 20232023Active

Board colleagues of Janardhana Reddy Ambati

NameDINCompanyDesignation
Nagarjuna Daram10285939Novarica Meditech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Novarica Meditech Private Limited
Premium access

Shareholding and investment profile for Janardhana Reddy Ambati

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Janardhana Reddy Ambati

Janardhana Reddy Ambati currently holds 1 directorship: Novarica Meditech Private Limited (Director, since 21 Aug 2023).

Janardhana Reddy Ambati was first appointed on 21 Aug 2023 as Director at Novarica Meditech Private Limited.

The current boards of Janardhana Reddy Ambati's companies include Nagarjuna Daram (Novarica Meditech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available